Updated Jul 16, 2026
Paolini John F. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.89M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-05 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 21.1K | $54.04 | $1.14M |
| 2026-05-05 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 37.3K | $53.52 | $2.00M |
| 2026-05-05 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 58.4K | $10.36 | $605K |
| 2026-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture | 1.2K | $48.94 | $59K |
| 2026-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 2.5K | — | |
| 2026-04-03 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture | 2.8K | $48.13 | $136K |
| 2026-04-03 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 5.8K | — | |
| 2026-03-04 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale [10b5-1] | 5.7K | $45.92 | $262K |
| 2026-03-04 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale [10b5-1] | 22.2K | $44.88 | $997K |
| 2026-03-04 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale [10b5-1] | 12.1K | $44.20 | $533K |
| 2026-03-04 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise [10b5-1] | 40.0K | $10.36 | $414K |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture | 835 | $34.28 | $29K |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 1.7K | — | |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture | 2.8K | $33.49 | $95K |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 2.5K | — | |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 1.6K | — | |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 1.8K | — | |
| 2025-08-06 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 29.3K | $32.55 | $955K |
| 2025-08-06 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 29.3K | $3.80 | $111K |
Paolini John F. is a corporate insider — currently tracked as Insider of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($5.89M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Paolini John F. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.